CLINICAL_TRIALS ClinicalTrials.gov record update

Predictive Effect of TGF-β Combined With INS-PI3K-AKT Signaling Pathway Related Proteins (ADNP, MAP6, Pgc-1α) for POD in Diabetes Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06426953
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:14.390032+00:00
Published At: 2025-09-29T00:00:00+00:00
Record Updated At: 2025-09-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diabetes", "Postoperative Delirium"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-29"
protocolSection.identificationModule.nctId: "NCT06426953"
protocolSection.identificationModule.officialTitle: "Predictive Effect of TGF-\u03b2 Combined With INS-PI3K-AKT Signaling Pathway Related Proteins (ADNP, MAP6, Pgc-1\u03b1) for POD in Diabetes Patients"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.